[老年患者的腹腔膜缺陷:一个病例报告]
Kazuhiro Tani1, Katsushi Ueyama, Reo Sakakura
1Department of Cardiovascular Surgery, Kanazawa Cardiovascular Hospital, Kanazawa, Japan.
Kyobu geka. The Japanese journal of thoracic surgery
|August 21, 2025
概括
一位85岁的女性患有大,未经治疗的腹腔隔膜缺陷 (VSD) 由于独特的解剖学, 几十年来没有心力衰竭. 这一案例强调了针对老年VSD患者的个性化手术.
科学领域:
- 心脏病学
- 出生的心脏病
- 老年医学
背景情况:
- 腹腔隔膜缺陷是一种常见的先天性心脏异常.
- 没有治疗的静脉病变很少发生.
- 晚期呈现通常涉及严重的并发症和心力衰竭.
研究的目的:
- 报告一个老年患者的大型未经治疗的VSD病例.
- 在这种罕见的情况中, 探索助长长期生存的因素.
- 讨论老年静脉疾病患者手术决策的影响.
主要方法:
- 一个85岁的女性患有呼吸障碍.
- 诊断评估包括心声学和心脏导管.
- 使用达克隆贴片进行手术关闭VSD.
主要成果:
- 患者出现了大VSD (12x16毫米) 和轻度肺高血压,但没有先前的心力衰竭.
- 最初没有心力衰竭的原因是肌肉缩限制了道流动.
- 在手术关闭VSD后,术后恢复情况良好.
结论:
- 特定的解剖学变异可以允许长期存活的大型,未经治疗的VSD.
- 渐进的右心室缩可能导致晚期心力衰竭.
- 对于患有静脉疾病的老年患者来说,个性化手术策略至关重要.
相关概念视频
Mitral Stenosis I: Introduction
34
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
34
Mitral Stenosis III: Medical Management
21
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21
Mitral Valve Prolapse II: Assessment and Management
39
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
39
Cardiomyopathy III: Hypertrophic Cardiomyopathy
47
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
47
Mitral Regurgitation I: Introduction
55
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
55
Cardiomyopathy II: Dilated Cardiomyopathy
22
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22


